Cargando…
Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model
Fabry disease is a X-linked lysosomal storage disorder caused by deficient function of the alpha-galactosidase A (α-GalA) enzyme. α-GalA deficiency leads to multisystemic clinical manifestations caused by the preferential accumulation of globotriaosylceramide (Gb3) in the endothelium and vascular sm...
Autores principales: | Lakomá, Jarmila, Rimondini, Roberto, Ferrer Montiel, Antonio, Donadio, Vincenzo, Liguori, Rocco, Caprini, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009828/ https://www.ncbi.nlm.nih.gov/pubmed/27531673 http://dx.doi.org/10.1177/1744806916663729 |
Ejemplares similares
-
Pain Related Channels Are Differentially Expressed in Neuronal and Non-Neuronal Cells of Glabrous Skin of Fabry Knockout Male Mice
por: Lakomá, Jarmila, et al.
Publicado: (2014) -
L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by
up-regulating type-2 metabotropic glutamate receptors
por: Formaggio, Francesco, et al.
Publicado: (2022) -
FXYD6 promotes thermal nociception by regulating TRPV1
por: Luo, Hao, et al.
Publicado: (2021) -
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy
por: Liguori, Rocco, et al.
Publicado: (2017) -
Sensitization of TRPV1 by EP(1 )and IP reveals peripheral nociceptive mechanism of prostaglandins
por: Moriyama, Tomoko, et al.
Publicado: (2005)